https://www.facebook.com/share/v/14SNNtbVSs7 ZAS Corporation proudly participated in the Bangladesh International Cancer Congress (BICC) 2025, highlighting its oncology and biosimilar portfolio aimed […]
https://www.facebook.com/share/v/1a9fjSn8TH ZAS Corporation was privileged to participate in the Anesthesia Day 2025 Celebration, reaffirming its commitment to advancing anesthesia practice
ZAS Industries proudly announces the launch of a new range of premium wound care products from Pharmaplast, a global leader
ZAS Corporation is proud to collaborate with the Rheumatology Department of BIRDEM General Hospital to introduce three world-class biosimilar therapies
ZAS Corporation Ltd. was honored to take part in the 33rd International Scientific Conference & 51st AGM of the Obstetrical
ZAS Corporation’s Dermatology Division recently organized a Continuing Medical Education (CME) program at BIDSA, focusing on “The Role of Adalimumab
ZAS Corporation recently organized a series of training sessions across multiple hospitals, engaging ICU nurses on the safe and effective
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh (MOSB), recently organized
ZAS Ophthalmic, a concern of ZAS Group, proudly launched two innovative ophthalmic products — Timo-COMOD and Pollival — in the